Australia markets closed

BioNeutra Global Corporation (BGA.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.10000.0000 (0.00%)
At close: 12:04PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
11,383
11,383
13,391
15,401
24,116
Cost of revenue
7,240
7,240
11,042
12,510
20,172
Gross profit
4,143
4,143
2,348
2,891
3,944
Operating expenses
Research development
146.313
146.313
-16.422
11.585
257.307
Selling general and administrative
4,123
4,123
3,922
4,166
4,317
Total operating expenses
5,581
5,581
4,815
5,246
6,970
Operating income or loss
-1,438
-1,438
-2,467
-2,355
-3,026
Interest expense
697.23
697.23
450.32
390.64
433.151
Total other income/expenses net
-89.55
-89.55
-4.541
-87.027
-316.505
Income before tax
-2,108
-2,108
-2,921
-2,830
-3,772
Income tax expense
0
0
0
0
-64.8
Income from continuing operations
-2,108
-2,108
-2,921
-2,830
-3,707
Net income
-2,108
-2,108
-2,921
-2,830
-3,707
Net income available to common shareholders
-2,108
-2,108
-2,921
-2,830
-3,707
Basic EPS
-0.06
-
-0.06
-0.06
-0.08
Diluted EPS
-0.06
-
-0.06
-0.06
-0.08
Basic average shares
46,449
-
46,449
46,449
46,449
Diluted average shares
46,449
-
46,449
46,449
46,449